<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="83834">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02013921</url>
  </required_header>
  <id_info>
    <org_study_id>I12040</org_study_id>
    <nct_id>NCT02013921</nct_id>
  </id_info>
  <brief_title>Interest of Daily Physical Activity After Cancer Treatment</brief_title>
  <acronym>APQ</acronym>
  <official_title>Evaluation du Niveau d'activité Physique Quotidien, Chez Des Patientes Porteuses d'un Cancer du Sein en période Post thérapeutique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Limoges</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Limoges</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many studies have demonstrated the beneficial effects of Adapted Physical Activity (APA) in
      different cancer types.

      It therefore seems necessary to assess spontaneous Physical Activity in order to integrate
      it to the overall calculation of physical activity in clinical practice.

      To assess the AP, two types of methods are validated : the subjective method using a
      questionnaries and objective method using a pedometer , accelerometer or measures
      calorimetry .

      Subjective method shows , good acceptability by patients and low cost but can sometimes lead
      to poor estimation of the level of activity.

      Objective methods obviously increase the accuracy of assessments but are more difficult to
      use for epidemiological studies , less accepted by the patient and more expensive.

      In this study the investigators will measure the spontaneous Daily Physical Activity by both
      methods andd evaluate the correclation.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Daily physical activity assessment at 3 months</measure>
    <time_frame>Month 3</time_frame>
    <description>Physical activity is measured by means of an Actigraph. Patients will measure their daily physical activity , three times during one week espaced by 1 month.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cancer</condition>
  <condition>Tiredness</condition>
  <arm_group>
    <arm_group_label>Physical Activity</arm_group_label>
    <description>Patients with a breast cancer and are completing treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical activity</intervention_name>
    <arm_group_label>Physical Activity</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a breast cancer and are completing treatment
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult (age ≥ 18 years)

          -  Having been informed of the study orally and in writing and have not expressed
             opposition to his participation

          -  Performance status &lt;2

          -  Invasive breast adenocarcinoma, histologically documented.

          -  Patients with a breast cancer and are completing treatment

          -  Exclusion Criteria:

          -  Patient with metastatic cancer.

          -  Patient for which monitoring required by the protocol is impossible.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicole TUBIANA, MD</last_name>
    <phone>0555056398</phone>
    <email>oncologie@chu-limoges.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sandrine LAVAUD-DENES, MD</last_name>
    <phone>0555056398</phone>
    <email>sandrine.lavaud-denes@chu-limoges.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oncologie- CHU Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>sandrine LAVAUD-DENES, MD</last_name>
      <phone>0555056398</phone>
      <email>sandrine.lavaud-denes@chu-limoges.fr</email>
    </contact>
    <investigator>
      <last_name>Sandrine LAVAUD-DENES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <lastchanged_date>August 31, 2015</lastchanged_date>
  <firstreceived_date>November 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Physical activity</keyword>
  <keyword>Cancer</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
